Columbus Venture Capital

Jurata Thin Film specializes in innovative storage technology for vaccines and biologics, focusing on enhancing the manufacturing, distribution, and delivery processes. The company has developed a unique thin film matrix that stabilizes biological materials, including bacterial-based vaccines and antibody-based therapeutics. This technology allows for the long-term storage of these products at room temperature or higher, ensuring their therapeutic efficacy even in extreme conditions. The thin film can be rehydrated to recover the therapeutic payload in an aqueous solution, facilitating diverse delivery routes. By simplifying the complexities associated with vaccine and biologic storage, Jurata Thin Film aims to improve accessibility and reliability in the healthcare sector.

Yola, Inc., formerly known as Synthasite, Inc., is a San Francisco-based company that offers a cloud-based website building platform. Founded in 2007, Yola empowers users to create professional-quality websites without the need for coding skills. The platform supports multiple languages, including English, French, German, Italian, Portuguese, and Spanish, and caters to a diverse global audience with over 13 million users in more than 175 countries. Yola provides a freemium model, allowing customers to develop websites quickly and easily from any device. Additionally, the company partners with various enterprises to extend its services to small and medium-sized businesses, enhancing their online presence through customizable and mobile-friendly website solutions.